Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
about
Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection.The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model.Protective Effects of Oral Astaxanthin Nanopowder against Ultraviolet-Induced Photokeratitis in Mice.Effects of the Macular Carotenoid Lutein in Human Retinal Pigment Epithelial Cells.Negative effects of divalent mineral cations on the bioaccessibility of carotenoids from plant food matrices and related physical properties of gastro-intestinal fluids.Lutein, zeaxanthin and mammalian development: Metabolism, functions and implications for health.Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats.Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration.Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine
P2860
Q37673168-BE49A286-A290-4446-814F-34B7BEEB74B1Q38692816-A2DE49D4-2BD3-4BCB-B73C-16093C6910F2Q39486132-9D696885-1AD1-4DD6-B2DE-64028C340F22Q41111119-3675A80A-AC12-4BC9-A5EF-C1A5B9C43FC4Q43113335-3E213471-FE31-4FF4-A98C-A2392234F454Q47096013-6241E019-226A-4C5A-9B06-5F87BAEC1AC4Q48235423-B4D38884-728B-4C8E-8E04-0DB4CEBDAD6DQ52588804-903FD354-D3BE-4489-B981-24A0C2F7FFF9Q55113695-08384C82-CC24-449F-9A68-F13C56241F78Q55491304-C8462B61-59D0-4E66-9FBB-FC37EB669718Q58702202-D48C46C2-84C7-40D4-BB39-ADD18C7B8ECD
P2860
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@ast
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@en
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@nl
type
label
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@ast
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@en
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@nl
prefLabel
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@ast
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@en
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@nl
P2093
P2860
P356
P1476
Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease
@en
P2093
Dan-Ning Hu
Nicole K Scripsema
Richard B Rosen
P2860
P304
P356
10.1155/2015/865179
P407
P577
2015-01-01T00:00:00Z